Blossom Pro: Research Briefing #4 – Microdosing Risks, Managing Challenging Experiences, and DMT for TRD
The risks of microdosing, challenging experience of psychedelics, and the promise of short-lasting DMT for TRD.
The risks of microdosing, challenging experience of psychedelics, and the promise of short-lasting DMT for TRD.
Investigating psychedelics in trials that we haven’t seen there before (ayahuasca and ibogaine), plus the psychological factors in MDMA-assisted therapy
December’s psychedelic research (2023) looked at group therapy, personality, costs and microdosing LSD. We added 22 articles to the database.
This link page serves as a centralized overview of psychedelic research studies published in 2024 that are not featured with individual pages in our database.
It’s a long and bumpy road ahead before we see psychedelics as medicines generally accepted. Here is my take on the recently presented pyramid by Tadeausz Hawrot.